retatrutide phase 2 trial obesity nejm 2023 triple agonist 🚨 BREAKING: Shows “Bariatric-Level” Weight Loss in 3 New Phase 3 TRIUMPH-1 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most Triple-Hormone-Receptor Agonist Retatrutide for... :

Gastrointestinal Protection Extensive Research Extensive research demonstrates powerful cytoprotective properties throughout the gastrointestinal tract, with studies showing protection against NSAID-induced gastric lesions, alcohol-induced stomach damage, and stress ulcers

Avoid cruciferous vegetables like broccoli and cabbage temporarily, as they ferment easily and produce additional gas in your slowed stomach

This makes it a safe and effective treatment option for diabetic patients interested in weight loss

The peptides amino acid sequence creates a structure that remains stable under conditions that would destroy most similar compounds